LAPTM4B and renal cell carcinoma: To evaluate whether LAPTM4B is involved in RCC apoptosis, as shown in Figures 8A, B, LAPTM4B was knocked out; caspase 3/4 activity in both types of cells was found to be significantly increased (p < 0.0001), as a result, compared to that in shCtrl cells.